Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Amgen: MariTide's Progress, Reassessment Of The Horizon Acquisition
06:10am, Thursday, 25'th Sep 2025
Amgen has not been a great performer in the last two years. Investors became and remain skeptical of MariTide's prospects in obesity, type 2 diabetes, and other related indications. I continue to see
Amgen quarterly profit rises 15% as Horizon deal boosts results
04:05pm, Tuesday, 06'th Feb 2024
Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Thera
Cramer names biopharma companies to watch as industry mergers start to pile up
07:02pm, Friday, 05'th Jan 2024
CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
5 Biotech Acquisition Targets To Accumulate In 2024
01:05pm, Thursday, 21'st Dec 2023
Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provid
Amgen: Horizon's Pipeline May Be Too Expensive
02:00pm, Friday, 13'th Oct 2023
We believe that AMGN has overpaid for HZNP's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. The growing debt may also pose headwinds to its
Amgen completes $27.8 bln Horizon deal
09:18am, Friday, 06'th Oct 2023
Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions
Horizon Therapeutics (HZNP) Up 10.4% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 07'th Sep 2023
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
3 Growth Stocks to Buy in September
10:56am, Wednesday, 06'th Sep 2023
We're now into September, and that means many investors wonder if the September effect will be in place. This speaks to the historical trend of stocks underperforming in September compared to other mo
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
12:56pm, Tuesday, 05'th Sep 2023
Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
09:05am, Tuesday, 05'th Sep 2023
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement.
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
02:11pm, Friday, 01'st Sep 2023
The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
FTC clears Amgen's $28 billion acquisition of Horizon Therapeutics
11:59am, Friday, 01'st Sep 2023
Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceut
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
10:53am, Friday, 01'st Sep 2023
The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.
Amgen, Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger
10:11am, Friday, 01'st Sep 2023
The Federal Trade Commission makes provision that prohibits “bundling” discounts for some medications.
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal
09:33am, Friday, 01'st Sep 2023
CNBC's Emily Wilkins joins 'Squawk Box' with the latest news.
